Learning Objectives:
After completing this activity, the learner will be able to:
- Identify and assess perimenopausal depression to recommend the most suitable treatment.
- Summarize the treatment options for perimenopausal depression and prescribe them accordingly.
Original Release Date: April 1, 2020
Review Date: March 1, 2024
Expiration Date: April 1, 2024
Relevant Financial Disclosures:
Vivien K. Burt declares the following interests:
- Sage Pharmaceuticals: speaker training/presentations
- Sage Pharmaceuticals: stockholder
- Merck: stockholder
- Johnson & johnson: stockholder
- Sage Pharmaceuticals: speaking
- Acadia Pharmaceuticals: advisory committee
- Johnson and Johnson: stock holder
- Merck: stockholder
All of the relevant financial relationships listed above have been mitigated by Medical Academy and the Psychopharmacology Institute.
Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com
Instructions for Participation and Credit:
Participants must complete the activity online during the valid credit period that is noted above.
Follow these steps to earn CME credit:
-
View the required educational content provided on this course page.
-
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
-
Download your certificate.
